홈 › 유방암 › 노스캐롤라이나

노스캐롤라이나의 유방암 임상 시험

유방암 관련 연구 91개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

The Vanguard Study: Testing a New Way to Screen for Cancer

UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Durham VA Medical Center, Durham

피험자 모집 중건강한 지원자 환영

45세 ~ 75세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06995898

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT02422641

A Study of PHST001 in Advanced Solid Tumors

Duke Cancer Institute, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Duke University, Durham

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Duke Cancer Network, Durham
Cone Health Cancer Center, Greensboro

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05827081

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
외 6개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Levine Cancer, Charlotte

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07102381

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

University of North Carolina, Chapel Hill

피험자 모집 중2상건강한 지원자 환영

18세 ~ 45세 · 여성 · 2026. 10. 1. 업데이트됨 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06369285

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07360314

Radiation Therapy and Thymus Function in Young Women With Breast Cancer

Duke Cancer Center, Durham

피험자 모집 중관찰 연구

18세 ~ 50세 · 여성 · 2026. 9. 29. 업데이트됨 · NCT07725172

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Duke Cancer Center, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06120283

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians

University of North Carolina, Chapel Hill

피험자 모집 중관찰 연구건강한 지원자 환영

전 연령 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05440929

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Novant Health Cancer Institute ( Site 0019), Charlotte
Novant Health Oncology Specialists ( Site 0074), Winston-Salem

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Levine Cancer Institute ( Site 0014), Charlotte

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Levine Cancer Institute, Albemarle
Levine Cancer Institute, Charlotte
Levine Cancer Institute, Charlotte
외 11개

피험자 모집 중3상

60세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06377852

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Duke Cancer Institute, Durham

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Carolinas Medical Center/Levine Cancer Institute, Charlotte

피험자 모집 중

30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Atrium Levine Cancer Institute, Charlotte

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Charlotte
Clinical Trial Site, Durham

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Duke University Medical Center, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Messino Cancer Centers, Asheville
WakeMed Cancer Care - Waverly Hematology & Medical Oncology, Cary
University of North Carolina Medical Center, Chapel Hill
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of North Carolina Medical Center, Chapel Hill

피험자 모집 중2상

18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07287098

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Atrium Health, Charlotte

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

Duke University Medical Cente, Durham

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 74세 · 여성 · 2026. 9. 18. 업데이트됨 · NCT06512350

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Oncology Specialists of Charlotte Pa, Charlotte
Carolina Oncology Specialists, Charlotte

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07685938

Utility of a Mobile Application for Young Women With Breast Cancer

Atrium Health Levine Cancer, Charlotte

피험자 모집 중

18세 ~ 45세 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07009093

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Duke Cancer Institute, Durham
Cape Fear Valley Medical Center, Fayetteville
Cone Health Cancer Center at Wesley Long, Greensboro

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

University of North Carolina at Chapel Hill, Chapel Hill

피험자 모집 중관찰 연구

20세 ~ 74세 · 여성 · 2026. 9. 14. 업데이트됨 · NCT07214610

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Charlotte

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Duke Cancer Institute, Durham

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT03424005

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Duke Cancer Institute, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
Novant Health Oncology Specialists, Winston-Salem

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07100106

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Duke Cancer Institute, Durham

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Novant Health Cancer Institute, Charlotte
Duke Cancer Institute, Durham
Novant Health Cancer Institute, Winston-Salem

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06790693

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Duke University, Durham

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT05846789

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

University of North Carolina, Chapel Hill

피험자 모집 중2상

50세 이상 · 여성 · 2026. 9. 3. 업데이트됨 · NCT06902311

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.